Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class I drug recalls - the high-risk category

Class I is the FDA's most serious recall category: a reasonable probability that using the product will cause serious health consequences or death. It is a small share of all recalls, but the one to check first if a medication you take appears here.

1,750 recalls, newest first.

Class I · High risk

8.4% Sodium Bicarbonate Injection

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Terminated Packaging defect Exela Pharma Sciences LLC NDC 72572-740-20 D-0023-2023
Class I · High risk

8.4% Sodium Bicarbonate Injection

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Terminated Packaging defect Exela Pharma Sciences LLC NDC 51754-5001-5 D-0022-2023
Class I · High risk

Atenolol Tablets

Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

Terminated Labeling / mix-up Golden State Medical Supply Inc. NDC 60429-027-10 D-0019-2023
Class I · High risk

Walgreens

Microbial contamination of non-sterile products.

Terminated Microbial contamination Vi-Jon, LLC NDC 0363-7162-38 D-1510-2022
Class I · High risk

Walgreens

Microbial contamination of non-sterile products.

Terminated Microbial contamination Vi-Jon, LLC NDC 0363-8166-38 D-1509-2022
Class I · High risk

Swan

Microbial contamination of non-sterile products.

Terminated Microbial contamination Vi-Jon, LLC NDC 0869-0166-38 D-1507-2022
Class I · High risk

Rexall

Microbial contamination of non-sterile products.

Terminated Microbial contamination Vi-Jon, LLC NDC 55910-183-38 D-1506-2022
Class I · High risk

meijer

Microbial contamination of non-sterile products.

Terminated Microbial contamination Vi-Jon, LLC NDC 41250-708-38 D-1504-2022
Class I · High risk

Kroger

Microbial contamination of non-sterile products.

Terminated Microbial contamination Vi-Jon, LLC NDC 30142-899-38 D-1503-2022
Class I · High risk

Insulin Glargine

Labeling: Missing label: Label missing from some prefilled pens.

Terminated Labeling / mix-up Mylan Pharmaceuticals Inc NDC 49502-394-71 D-1292-2022
Class I · High risk

Launch Sequence Aphrodisia Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1338-2022
Class I · High risk

Launch Sequence Euphoria Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1337-2022
Class I · High risk

Launch Sequence Capsules

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Terminated Chemical / undeclared Loud Muscle Science D-1336-2022

Recalls by year